Stay updated on Pembrolizumab & Endocrine Therapy Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab & Endocrine Therapy Clinical Trial page.

Latest updates to the Pembrolizumab & Endocrine Therapy Clinical Trial page
- Check2 days agoChange DetectedThe change is a minor version update (from v3.4.1 to v3.4.2) with no impact on study data, eligibility, or displayed content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check10 days agoChange DetectedThe footer revision changed from v3.4.0 to v3.4.1; there is no change to core content such as study details, eligibility criteria, or trial results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check17 days agoChange DetectedThe page now includes a 'Show glossary' option and displays 'Last Update Submitted that Met QC Criteria' along with 'No FEAR Act Data' and 'Revision: v3.4.0'. The previous labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed.SummaryDifference0.2%

- Check32 days agoChange DetectedRevision label updated from v3.3.3 to v3.3.4 (metadata only), and this does not affect study content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check54 days agoChange DetectedAdded a dedicated Locations section with California sites; removed the California Locations subsection and the HHS Vulnerability Disclosure link, and updated the page revision to v3.3.3.SummaryDifference0.2%

- Check68 days agoChange DetectedThe page now displays 'Results Submitted' in the Results section, replacing 'No Results Posted.' This indicates that trial results have been submitted to ClinicalTrials.gov but are not yet posted.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab & Endocrine Therapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Endocrine Therapy Clinical Trial page.